カテゴリー： LP Information, 世界, 部品/材料

世界の酢酸エスリカルバゼピンAPI市場予測 2023年-2029年

◆英語タイトル：Global Eslicarbazepine Acetate API Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU6555）◆商品コード：LP23JU6555
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：102
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の酢酸エスリカルバゼピンAPI市場」は、過去の販売実績から2022年の世界の酢酸エスリカルバゼピンAPIの総販売量を検討し、2023年から2029年の予測される酢酸エスリカルバゼピンAPIの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の酢酸エスリカルバゼピンAPIの市場規模を掲載し、XXX百万米ドル規模の世界の酢酸エスリカルバゼピンAPI市場の詳細な分析を提供します。本インサイトレポートは、世界の酢酸エスリカルバゼピンAPI業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の酢酸エスリカルバゼピンAPI市場における各社の独自のポジションをより深く理解するために、酢酸エスリカルバゼピンAPI製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の酢酸エスリカルバゼピンAPI市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。酢酸エスリカルバゼピンAPIの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。酢酸エスリカルバゼピンAPIの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。酢酸エスリカルバゼピンAPIのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

酢酸エスリカルバゼピンAPIの世界主要メーカーとしては、Tecoland、 Dr. Reddy’s Laboratories、 Clearsynth、 Jigs chemical、 Triveni Interchem、 Jubilant Life Sciences、 ZCL Chemicals、 Lupin、 Vasoya Industries、 Ami Lifesciences、 Shangyao Kony (Changzhou) Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の酢酸エスリカルバゼピンAPI市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では酢酸エスリカルバゼピンAPI市場をセグメンテーションし、種類別 (純度98%以下、純度98%～99%、純度99%以上)、用途別 (研究、製薬)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度98%以下、純度98%～99%、純度99%以上

・用途別区分：研究、製薬

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の酢酸エスリカルバゼピンAPI市場の10年間の市場状況・展望は？
・世界および地域別に見た酢酸エスリカルバゼピンAPI市場成長の要因は何か？
・酢酸エスリカルバゼピンAPIの市場機会はエンドマーケットの規模によってどのように変化するのか？
・酢酸エスリカルバゼピンAPIのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：酢酸エスリカルバゼピンAPIの年間販売量2018-2029、地域別現状・将来分析
・酢酸エスリカルバゼピンAPIの種類別セグメント：純度98%以下、純度98%～99%、純度99%以上
・酢酸エスリカルバゼピンAPIの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・酢酸エスリカルバゼピンAPIの用途別セグメント：研究、製薬
・酢酸エスリカルバゼピンAPIの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の酢酸エスリカルバゼピンAPI市場
・企業別のグローバル酢酸エスリカルバゼピンAPI市場データ：2018-2023年の年間販売量、市場シェア
・企業別の酢酸エスリカルバゼピンAPIの年間売上：2018-2023年の売上、市場シェア
・企業別の酢酸エスリカルバゼピンAPI販売価格
・主要企業の酢酸エスリカルバゼピンAPI生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

酢酸エスリカルバゼピンAPIの地域別レビュー
・地域別の酢酸エスリカルバゼピンAPI市場規模2018-2023：年間販売量、売上
・主要国別の酢酸エスリカルバゼピンAPI市場規模2018-2023：年間販売量、売上
・南北アメリカの酢酸エスリカルバゼピンAPI販売の成長
・アジア太平洋の酢酸エスリカルバゼピンAPI販売の成長
・ヨーロッパの酢酸エスリカルバゼピンAPI販売の成長
・中東・アフリカの酢酸エスリカルバゼピンAPI販売の成長

南北アメリカ市場
・南北アメリカの国別の酢酸エスリカルバゼピンAPI販売量、売上（2018-2023）
・南北アメリカの酢酸エスリカルバゼピンAPIの種類別販売量
・南北アメリカの酢酸エスリカルバゼピンAPIの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の酢酸エスリカルバゼピンAPI販売量、売上（2018-2023）
・アジア太平洋の酢酸エスリカルバゼピンAPIの種類別販売量
・アジア太平洋の酢酸エスリカルバゼピンAPIの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の酢酸エスリカルバゼピンAPI販売量、売上（2018-2023）
・ヨーロッパの酢酸エスリカルバゼピンAPIの種類別販売量
・ヨーロッパの酢酸エスリカルバゼピンAPIの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の酢酸エスリカルバゼピンAPI販売量、売上（2018-2023）
・中東・アフリカの酢酸エスリカルバゼピンAPIの種類別販売量
・中東・アフリカの酢酸エスリカルバゼピンAPIの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・酢酸エスリカルバゼピンAPIの製造コスト構造分析
・酢酸エスリカルバゼピンAPIの製造プロセス分析
・酢酸エスリカルバゼピンAPIの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・酢酸エスリカルバゼピンAPIの主要なグローバル販売業者
・酢酸エスリカルバゼピンAPIの主要なグローバル顧客

地域別の酢酸エスリカルバゼピンAPI市場予測レビュー
・地域別の酢酸エスリカルバゼピンAPI市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・酢酸エスリカルバゼピンAPIの種類別市場規模予測
・酢酸エスリカルバゼピンAPIの用途別市場規模予測

主要企業分析
Tecoland、 Dr. Reddy’s Laboratories、 Clearsynth、 Jigs chemical、 Triveni Interchem、 Jubilant Life Sciences、 ZCL Chemicals、 Lupin、 Vasoya Industries、 Ami Lifesciences、 Shangyao Kony (Changzhou) Pharmaceutical
・企業情報
・酢酸エスリカルバゼピンAPI製品
・酢酸エスリカルバゼピンAPI販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Eslicarbazepine acetate is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or as additional therapy for partial-onset seizures epilepsy.
LPI (LP Information)’ newest research report, the “Eslicarbazepine Acetate API Industry Forecast” looks at past sales and reviews total world Eslicarbazepine Acetate API sales in 2022, providing a comprehensive analysis by region and market sector of projected Eslicarbazepine Acetate API sales for 2023 through 2029. With Eslicarbazepine Acetate API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eslicarbazepine Acetate API industry.
This Insight Report provides a comprehensive analysis of the global Eslicarbazepine Acetate API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eslicarbazepine Acetate API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Eslicarbazepine Acetate API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eslicarbazepine Acetate API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eslicarbazepine Acetate API.
The global Eslicarbazepine Acetate API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Eslicarbazepine Acetate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Eslicarbazepine Acetate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Eslicarbazepine Acetate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Eslicarbazepine Acetate API players cover Tecoland, Dr. Reddy’s Laboratories, Clearsynth, Jigs chemical, Triveni Interchem, Jubilant Life Sciences, ZCL Chemicals, Lupin and Vasoya Industries, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Eslicarbazepine Acetate API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segmentation by application
Research
Pharmaceutical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Tecoland
Dr. Reddy’s Laboratories
Clearsynth
Jigs chemical
Triveni Interchem
Jubilant Life Sciences
ZCL Chemicals
Lupin
Vasoya Industries
Ami Lifesciences
Shangyao Kony (Changzhou) Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Eslicarbazepine Acetate API market?
What factors are driving Eslicarbazepine Acetate API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Eslicarbazepine Acetate API market opportunities vary by end market size?
How does Eslicarbazepine Acetate API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Eslicarbazepine Acetate API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Eslicarbazepine Acetate API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Eslicarbazepine Acetate API by Country/Region, 2018, 2022 & 2029
2.2 Eslicarbazepine Acetate API Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Eslicarbazepine Acetate API Sales by Type
2.3.1 Global Eslicarbazepine Acetate API Sales Market Share by Type (2018-2023)
2.3.2 Global Eslicarbazepine Acetate API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Eslicarbazepine Acetate API Sale Price by Type (2018-2023)
2.4 Eslicarbazepine Acetate API Segment by Application
2.4.1 Research
2.4.2 Pharmaceutical
2.5 Eslicarbazepine Acetate API Sales by Application
2.5.1 Global Eslicarbazepine Acetate API Sale Market Share by Application (2018-2023)
2.5.2 Global Eslicarbazepine Acetate API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Eslicarbazepine Acetate API Sale Price by Application (2018-2023)
3 Global Eslicarbazepine Acetate API by Company
3.1 Global Eslicarbazepine Acetate API Breakdown Data by Company
3.1.1 Global Eslicarbazepine Acetate API Annual Sales by Company (2018-2023)
3.1.2 Global Eslicarbazepine Acetate API Sales Market Share by Company (2018-2023)
3.2 Global Eslicarbazepine Acetate API Annual Revenue by Company (2018-2023)
3.2.1 Global Eslicarbazepine Acetate API Revenue by Company (2018-2023)
3.2.2 Global Eslicarbazepine Acetate API Revenue Market Share by Company (2018-2023)
3.3 Global Eslicarbazepine Acetate API Sale Price by Company
3.4 Key Manufacturers Eslicarbazepine Acetate API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eslicarbazepine Acetate API Product Location Distribution
3.4.2 Players Eslicarbazepine Acetate API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Eslicarbazepine Acetate API by Geographic Region
4.1 World Historic Eslicarbazepine Acetate API Market Size by Geographic Region (2018-2023)
4.1.1 Global Eslicarbazepine Acetate API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Eslicarbazepine Acetate API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Eslicarbazepine Acetate API Market Size by Country/Region (2018-2023)
4.2.1 Global Eslicarbazepine Acetate API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Eslicarbazepine Acetate API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Eslicarbazepine Acetate API Sales Growth
4.4 APAC Eslicarbazepine Acetate API Sales Growth
4.5 Europe Eslicarbazepine Acetate API Sales Growth
4.6 Middle East & Africa Eslicarbazepine Acetate API Sales Growth
5 Americas
5.1 Americas Eslicarbazepine Acetate API Sales by Country
5.1.1 Americas Eslicarbazepine Acetate API Sales by Country (2018-2023)
5.1.2 Americas Eslicarbazepine Acetate API Revenue by Country (2018-2023)
5.2 Americas Eslicarbazepine Acetate API Sales by Type
5.3 Americas Eslicarbazepine Acetate API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eslicarbazepine Acetate API Sales by Region
6.1.1 APAC Eslicarbazepine Acetate API Sales by Region (2018-2023)
6.1.2 APAC Eslicarbazepine Acetate API Revenue by Region (2018-2023)
6.2 APAC Eslicarbazepine Acetate API Sales by Type
6.3 APAC Eslicarbazepine Acetate API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Eslicarbazepine Acetate API by Country
7.1.1 Europe Eslicarbazepine Acetate API Sales by Country (2018-2023)
7.1.2 Europe Eslicarbazepine Acetate API Revenue by Country (2018-2023)
7.2 Europe Eslicarbazepine Acetate API Sales by Type
7.3 Europe Eslicarbazepine Acetate API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Eslicarbazepine Acetate API by Country
8.1.1 Middle East & Africa Eslicarbazepine Acetate API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Eslicarbazepine Acetate API Revenue by Country (2018-2023)
8.2 Middle East & Africa Eslicarbazepine Acetate API Sales by Type
8.3 Middle East & Africa Eslicarbazepine Acetate API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eslicarbazepine Acetate API
10.3 Manufacturing Process Analysis of Eslicarbazepine Acetate API
10.4 Industry Chain Structure of Eslicarbazepine Acetate API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eslicarbazepine Acetate API Distributors
11.3 Eslicarbazepine Acetate API Customer
12 World Forecast Review for Eslicarbazepine Acetate API by Geographic Region
12.1 Global Eslicarbazepine Acetate API Market Size Forecast by Region
12.1.1 Global Eslicarbazepine Acetate API Forecast by Region (2024-2029)
12.1.2 Global Eslicarbazepine Acetate API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Eslicarbazepine Acetate API Forecast by Type
12.7 Global Eslicarbazepine Acetate API Forecast by Application
13 Key Players Analysis
13.1 Tecoland
13.1.1 Tecoland Company Information
13.1.2 Tecoland Eslicarbazepine Acetate API Product Portfolios and Specifications
13.1.3 Tecoland Eslicarbazepine Acetate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Tecoland Main Business Overview
13.1.5 Tecoland Latest Developments
13.2 Dr. Reddy’s Laboratories
13.2.1 Dr. Reddy’s Laboratories Company Information
13.2.2 Dr. Reddy’s Laboratories Eslicarbazepine Acetate API Product Portfolios and Specifications
13.2.3 Dr. Reddy’s Laboratories Eslicarbazepine Acetate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Dr. Reddy’s Laboratories Main Business Overview
13.2.5 Dr. Reddy’s Laboratories Latest Developments
13.3 Clearsynth
13.3.1 Clearsynth Company Information
13.3.2 Clearsynth Eslicarbazepine Acetate API Product Portfolios and Specifications
13.3.3 Clearsynth Eslicarbazepine Acetate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Clearsynth Main Business Overview
13.3.5 Clearsynth Latest Developments
13.4 Jigs chemical
13.4.1 Jigs chemical Company Information
13.4.2 Jigs chemical Eslicarbazepine Acetate API Product Portfolios and Specifications
13.4.3 Jigs chemical Eslicarbazepine Acetate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Jigs chemical Main Business Overview
13.4.5 Jigs chemical Latest Developments
13.5 Triveni Interchem
13.5.1 Triveni Interchem Company Information
13.5.2 Triveni Interchem Eslicarbazepine Acetate API Product Portfolios and Specifications
13.5.3 Triveni Interchem Eslicarbazepine Acetate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Triveni Interchem Main Business Overview
13.5.5 Triveni Interchem Latest Developments
13.6 Jubilant Life Sciences
13.6.1 Jubilant Life Sciences Company Information
13.6.2 Jubilant Life Sciences Eslicarbazepine Acetate API Product Portfolios and Specifications
13.6.3 Jubilant Life Sciences Eslicarbazepine Acetate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jubilant Life Sciences Main Business Overview
13.6.5 Jubilant Life Sciences Latest Developments
13.7 ZCL Chemicals
13.7.1 ZCL Chemicals Company Information
13.7.2 ZCL Chemicals Eslicarbazepine Acetate API Product Portfolios and Specifications
13.7.3 ZCL Chemicals Eslicarbazepine Acetate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 ZCL Chemicals Main Business Overview
13.7.5 ZCL Chemicals Latest Developments
13.8 Lupin
13.8.1 Lupin Company Information
13.8.2 Lupin Eslicarbazepine Acetate API Product Portfolios and Specifications
13.8.3 Lupin Eslicarbazepine Acetate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Lupin Main Business Overview
13.8.5 Lupin Latest Developments
13.9 Vasoya Industries
13.9.1 Vasoya Industries Company Information
13.9.2 Vasoya Industries Eslicarbazepine Acetate API Product Portfolios and Specifications
13.9.3 Vasoya Industries Eslicarbazepine Acetate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Vasoya Industries Main Business Overview
13.9.5 Vasoya Industries Latest Developments
13.10 Ami Lifesciences
13.10.1 Ami Lifesciences Company Information
13.10.2 Ami Lifesciences Eslicarbazepine Acetate API Product Portfolios and Specifications
13.10.3 Ami Lifesciences Eslicarbazepine Acetate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Ami Lifesciences Main Business Overview
13.10.5 Ami Lifesciences Latest Developments
13.11 Shangyao Kony (Changzhou) Pharmaceutical
13.11.1 Shangyao Kony (Changzhou) Pharmaceutical Company Information
13.11.2 Shangyao Kony (Changzhou) Pharmaceutical Eslicarbazepine Acetate API Product Portfolios and Specifications
13.11.3 Shangyao Kony (Changzhou) Pharmaceutical Eslicarbazepine Acetate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shangyao Kony (Changzhou) Pharmaceutical Main Business Overview
13.11.5 Shangyao Kony (Changzhou) Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Eslicarbazepine Acetate API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Eslicarbazepine Acetate API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Eslicarbazepine Acetate API Sales by Type (2018-2023) & (MT)
Table 7. Global Eslicarbazepine Acetate API Sales Market Share by Type (2018-2023)
Table 8. Global Eslicarbazepine Acetate API Revenue by Type (2018-2023) & ($ million)
Table 9. Global Eslicarbazepine Acetate API Revenue Market Share by Type (2018-2023)
Table 10. Global Eslicarbazepine Acetate API Sale Price by Type (2018-2023) & (USD/MT)
Table 11. Global Eslicarbazepine Acetate API Sales by Application (2018-2023) & (MT)
Table 12. Global Eslicarbazepine Acetate API Sales Market Share by Application (2018-2023)
Table 13. Global Eslicarbazepine Acetate API Revenue by Application (2018-2023)
Table 14. Global Eslicarbazepine Acetate API Revenue Market Share by Application (2018-2023)
Table 15. Global Eslicarbazepine Acetate API Sale Price by Application (2018-2023) & (USD/MT)
Table 16. Global Eslicarbazepine Acetate API Sales by Company (2018-2023) & (MT)
Table 17. Global Eslicarbazepine Acetate API Sales Market Share by Company (2018-2023)
Table 18. Global Eslicarbazepine Acetate API Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Eslicarbazepine Acetate API Revenue Market Share by Company (2018-2023)
Table 20. Global Eslicarbazepine Acetate API Sale Price by Company (2018-2023) & (USD/MT)
Table 21. Key Manufacturers Eslicarbazepine Acetate API Producing Area Distribution and Sales Area
Table 22. Players Eslicarbazepine Acetate API Products Offered
Table 23. Eslicarbazepine Acetate API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Eslicarbazepine Acetate API Sales by Geographic Region (2018-2023) & (MT)
Table 27. Global Eslicarbazepine Acetate API Sales Market Share Geographic Region (2018-2023)
Table 28. Global Eslicarbazepine Acetate API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Eslicarbazepine Acetate API Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Eslicarbazepine Acetate API Sales by Country/Region (2018-2023) & (MT)
Table 31. Global Eslicarbazepine Acetate API Sales Market Share by Country/Region (2018-2023)
Table 32. Global Eslicarbazepine Acetate API Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Eslicarbazepine Acetate API Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Eslicarbazepine Acetate API Sales by Country (2018-2023) & (MT)
Table 35. Americas Eslicarbazepine Acetate API Sales Market Share by Country (2018-2023)
Table 36. Americas Eslicarbazepine Acetate API Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Eslicarbazepine Acetate API Revenue Market Share by Country (2018-2023)
Table 38. Americas Eslicarbazepine Acetate API Sales by Type (2018-2023) & (MT)
Table 39. Americas Eslicarbazepine Acetate API Sales by Application (2018-2023) & (MT)
Table 40. APAC Eslicarbazepine Acetate API Sales by Region (2018-2023) & (MT)
Table 41. APAC Eslicarbazepine Acetate API Sales Market Share by Region (2018-2023)
Table 42. APAC Eslicarbazepine Acetate API Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Eslicarbazepine Acetate API Revenue Market Share by Region (2018-2023)
Table 44. APAC Eslicarbazepine Acetate API Sales by Type (2018-2023) & (MT)
Table 45. APAC Eslicarbazepine Acetate API Sales by Application (2018-2023) & (MT)
Table 46. Europe Eslicarbazepine Acetate API Sales by Country (2018-2023) & (MT)
Table 47. Europe Eslicarbazepine Acetate API Sales Market Share by Country (2018-2023)
Table 48. Europe Eslicarbazepine Acetate API Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Eslicarbazepine Acetate API Revenue Market Share by Country (2018-2023)
Table 50. Europe Eslicarbazepine Acetate API Sales by Type (2018-2023) & (MT)
Table 51. Europe Eslicarbazepine Acetate API Sales by Application (2018-2023) & (MT)
Table 52. Middle East & Africa Eslicarbazepine Acetate API Sales by Country (2018-2023) & (MT)
Table 53. Middle East & Africa Eslicarbazepine Acetate API Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Eslicarbazepine Acetate API Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Eslicarbazepine Acetate API Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Eslicarbazepine Acetate API Sales by Type (2018-2023) & (MT)
Table 57. Middle East & Africa Eslicarbazepine Acetate API Sales by Application (2018-2023) & (MT)
Table 58. Key Market Drivers & Growth Opportunities of Eslicarbazepine Acetate API
Table 59. Key Market Challenges & Risks of Eslicarbazepine Acetate API
Table 60. Key Industry Trends of Eslicarbazepine Acetate API
Table 61. Eslicarbazepine Acetate API Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Eslicarbazepine Acetate API Distributors List
Table 64. Eslicarbazepine Acetate API Customer List
Table 65. Global Eslicarbazepine Acetate API Sales Forecast by Region (2024-2029) & (MT)
Table 66. Global Eslicarbazepine Acetate API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Eslicarbazepine Acetate API Sales Forecast by Country (2024-2029) & (MT)
Table 68. Americas Eslicarbazepine Acetate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Eslicarbazepine Acetate API Sales Forecast by Region (2024-2029) & (MT)
Table 70. APAC Eslicarbazepine Acetate API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Eslicarbazepine Acetate API Sales Forecast by Country (2024-2029) & (MT)
Table 72. Europe Eslicarbazepine Acetate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Eslicarbazepine Acetate API Sales Forecast by Country (2024-2029) & (MT)
Table 74. Middle East & Africa Eslicarbazepine Acetate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Eslicarbazepine Acetate API Sales Forecast by Type (2024-2029) & (MT)
Table 76. Global Eslicarbazepine Acetate API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Eslicarbazepine Acetate API Sales Forecast by Application (2024-2029) & (MT)
Table 78. Global Eslicarbazepine Acetate API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Tecoland Basic Information, Eslicarbazepine Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 80. Tecoland Eslicarbazepine Acetate API Product Portfolios and Specifications
Table 81. Tecoland Eslicarbazepine Acetate API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Tecoland Main Business
Table 83. Tecoland Latest Developments
Table 84. Dr. Reddy’s Laboratories Basic Information, Eslicarbazepine Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 85. Dr. Reddy’s Laboratories Eslicarbazepine Acetate API Product Portfolios and Specifications
Table 86. Dr. Reddy’s Laboratories Eslicarbazepine Acetate API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Dr. Reddy’s Laboratories Main Business
Table 88. Dr. Reddy’s Laboratories Latest Developments
Table 89. Clearsynth Basic Information, Eslicarbazepine Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 90. Clearsynth Eslicarbazepine Acetate API Product Portfolios and Specifications
Table 91. Clearsynth Eslicarbazepine Acetate API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Clearsynth Main Business
Table 93. Clearsynth Latest Developments
Table 94. Jigs chemical Basic Information, Eslicarbazepine Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 95. Jigs chemical Eslicarbazepine Acetate API Product Portfolios and Specifications
Table 96. Jigs chemical Eslicarbazepine Acetate API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Jigs chemical Main Business
Table 98. Jigs chemical Latest Developments
Table 99. Triveni Interchem Basic Information, Eslicarbazepine Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 100. Triveni Interchem Eslicarbazepine Acetate API Product Portfolios and Specifications
Table 101. Triveni Interchem Eslicarbazepine Acetate API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Triveni Interchem Main Business
Table 103. Triveni Interchem Latest Developments
Table 104. Jubilant Life Sciences Basic Information, Eslicarbazepine Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 105. Jubilant Life Sciences Eslicarbazepine Acetate API Product Portfolios and Specifications
Table 106. Jubilant Life Sciences Eslicarbazepine Acetate API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Jubilant Life Sciences Main Business
Table 108. Jubilant Life Sciences Latest Developments
Table 109. ZCL Chemicals Basic Information, Eslicarbazepine Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 110. ZCL Chemicals Eslicarbazepine Acetate API Product Portfolios and Specifications
Table 111. ZCL Chemicals Eslicarbazepine Acetate API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. ZCL Chemicals Main Business
Table 113. ZCL Chemicals Latest Developments
Table 114. Lupin Basic Information, Eslicarbazepine Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 115. Lupin Eslicarbazepine Acetate API Product Portfolios and Specifications
Table 116. Lupin Eslicarbazepine Acetate API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Lupin Main Business
Table 118. Lupin Latest Developments
Table 119. Vasoya Industries Basic Information, Eslicarbazepine Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 120. Vasoya Industries Eslicarbazepine Acetate API Product Portfolios and Specifications
Table 121. Vasoya Industries Eslicarbazepine Acetate API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Vasoya Industries Main Business
Table 123. Vasoya Industries Latest Developments
Table 124. Ami Lifesciences Basic Information, Eslicarbazepine Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 125. Ami Lifesciences Eslicarbazepine Acetate API Product Portfolios and Specifications
Table 126. Ami Lifesciences Eslicarbazepine Acetate API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. Ami Lifesciences Main Business
Table 128. Ami Lifesciences Latest Developments
Table 129. Shangyao Kony (Changzhou) Pharmaceutical Basic Information, Eslicarbazepine Acetate API Manufacturing Base, Sales Area and Its Competitors
Table 130. Shangyao Kony (Changzhou) Pharmaceutical Eslicarbazepine Acetate API Product Portfolios and Specifications
Table 131. Shangyao Kony (Changzhou) Pharmaceutical Eslicarbazepine Acetate API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 132. Shangyao Kony (Changzhou) Pharmaceutical Main Business
Table 133. Shangyao Kony (Changzhou) Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Eslicarbazepine Acetate API
Figure 2. Eslicarbazepine Acetate API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eslicarbazepine Acetate API Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Eslicarbazepine Acetate API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Eslicarbazepine Acetate API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Eslicarbazepine Acetate API Sales Market Share by Type in 2022
Figure 13. Global Eslicarbazepine Acetate API Revenue Market Share by Type (2018-2023)
Figure 14. Eslicarbazepine Acetate API Consumed in Research
Figure 15. Global Eslicarbazepine Acetate API Market: Research (2018-2023) & (MT)
Figure 16. Eslicarbazepine Acetate API Consumed in Pharmaceutical
Figure 17. Global Eslicarbazepine Acetate API Market: Pharmaceutical (2018-2023) & (MT)
Figure 18. Global Eslicarbazepine Acetate API Sales Market Share by Application (2022)
Figure 19. Global Eslicarbazepine Acetate API Revenue Market Share by Application in 2022
Figure 20. Eslicarbazepine Acetate API Sales Market by Company in 2022 (MT)
Figure 21. Global Eslicarbazepine Acetate API Sales Market Share by Company in 2022
Figure 22. Eslicarbazepine Acetate API Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Eslicarbazepine Acetate API Revenue Market Share by Company in 2022
Figure 24. Global Eslicarbazepine Acetate API Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Eslicarbazepine Acetate API Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Eslicarbazepine Acetate API Sales 2018-2023 (MT)
Figure 27. Americas Eslicarbazepine Acetate API Revenue 2018-2023 ($ Millions)
Figure 28. APAC Eslicarbazepine Acetate API Sales 2018-2023 (MT)
Figure 29. APAC Eslicarbazepine Acetate API Revenue 2018-2023 ($ Millions)
Figure 30. Europe Eslicarbazepine Acetate API Sales 2018-2023 (MT)
Figure 31. Europe Eslicarbazepine Acetate API Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Eslicarbazepine Acetate API Sales 2018-2023 (MT)
Figure 33. Middle East & Africa Eslicarbazepine Acetate API Revenue 2018-2023 ($ Millions)
Figure 34. Americas Eslicarbazepine Acetate API Sales Market Share by Country in 2022
Figure 35. Americas Eslicarbazepine Acetate API Revenue Market Share by Country in 2022
Figure 36. Americas Eslicarbazepine Acetate API Sales Market Share by Type (2018-2023)
Figure 37. Americas Eslicarbazepine Acetate API Sales Market Share by Application (2018-2023)
Figure 38. United States Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Eslicarbazepine Acetate API Sales Market Share by Region in 2022
Figure 43. APAC Eslicarbazepine Acetate API Revenue Market Share by Regions in 2022
Figure 44. APAC Eslicarbazepine Acetate API Sales Market Share by Type (2018-2023)
Figure 45. APAC Eslicarbazepine Acetate API Sales Market Share by Application (2018-2023)
Figure 46. China Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Eslicarbazepine Acetate API Sales Market Share by Country in 2022
Figure 54. Europe Eslicarbazepine Acetate API Revenue Market Share by Country in 2022
Figure 55. Europe Eslicarbazepine Acetate API Sales Market Share by Type (2018-2023)
Figure 56. Europe Eslicarbazepine Acetate API Sales Market Share by Application (2018-2023)
Figure 57. Germany Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Eslicarbazepine Acetate API Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Eslicarbazepine Acetate API Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Eslicarbazepine Acetate API Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Eslicarbazepine Acetate API Sales Market Share by Application (2018-2023)
Figure 66. Egypt Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Eslicarbazepine Acetate API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Eslicarbazepine Acetate API in 2022
Figure 72. Manufacturing Process Analysis of Eslicarbazepine Acetate API
Figure 73. Industry Chain Structure of Eslicarbazepine Acetate API
Figure 74. Channels of Distribution
Figure 75. Global Eslicarbazepine Acetate API Sales Market Forecast by Region (2024-2029)
Figure 76. Global Eslicarbazepine Acetate API Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Eslicarbazepine Acetate API Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Eslicarbazepine Acetate API Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Eslicarbazepine Acetate API Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Eslicarbazepine Acetate API Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の酢酸エスリカルバゼピンAPI市場予測 2023年-2029年(Global Eslicarbazepine Acetate API Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の酢酸エスリカルバゼピン試薬市場予測 2023年-2029年
  • 世界の酢酸ゲラニル 60市場予測 2023年-2029年
  • 世界の酢酸アニシル市場予測 2023年-2029年
  • 世界の酢酸シトロネリル市場予測 2023年-2029年
  • 世界のイソプロペニルアセテート市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆